Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Transferases
Reexamination Certificate
2005-08-30
2005-08-30
Saidha, Tekchand (Department: 1652)
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Transferases
C435S194000, C435S015000
Reexamination Certificate
active
06936245
ABSTRACT:
Polypeptides capable of regulating signal transduction, which preferably exhibit kinase activity, or antibodies against such polypeptides that inhibit the interaction of these polypeptides with other mediators of signal transduction, may be used in the identification, prevention or treatment of disease, preferably cardiac disease, in mammalian hosts. In addition, these polypeptides can facilitate the identification or isolation of additional mediators of signal transduction associated with disease, preferably cardiac disease, which in turn may also be used in the identification, prevention or treatment of disease, preferably cardiac disease, in mammals.
REFERENCES:
Adams, et al.,Journal of Cell Biology, 111:131-142, Jul. 1990, “CDC42 and CDC43, Two Additional Genes Involved in Budding and the Establishment of Cell Polarity in the YeastSaccharomyces cerevisiae.”
Aepfelbacher, et al.,Proc. Natl. Acad. Sci. USA, 91:4263-4267, May 1994, “Spreading of differentiating human monocytes is associated with a major increase in membrane-bound CDC42.”
Altschul, et al.,Nucleic Acids Research, 25(17):3389-3402, 1997, “Gapped Blast and PSI-Blast: a new generation of protein database search programs.”
Braga, et al.,Journal of Cell Biology, 137(6):1421-1431, Jun. 16, 1997, “The Small GTPases Rho and Rac Are Required for the Establishment of Cadherin-dependent Cell-Cell Contacts.”
Brenner, et al.,Journal of Biological Chemistry, 272(35):22173-22181, Aug. 29, 1997, “Fas- or Ceramide-induced Apoptosis Is Mediated by a Rac1-regulated Activation of Jun N-terminal Kinase/p38 Kinases and GADD153.”
Cherfils, J. and P. Chardin,TIBS, 24:306-311, Aug. 1999, “GEFs: structural basis for their activation of small GTP-binding proteins.”
Coso, et al.,Cell, 81:1137-1146, Jun. 30, 1995, “The Small GTP-Binding Proteins Rac1 and Cdc42 Regulate the Activity of the JNK/SAPK Signaling Pathway.”
Debant, et al.,Proc. Natl. Acad. Sci. USA, 93:5466-5471, May 1996, “The multidomain protein Trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate rac-specific and rho-specific guanine nucleotide exchange factor domains.”
Dutartre, et al.,Journal of Cell Science, 109:367-377, 1996, “Cytokinesis arrest and redistribution of actin-cytoskeleton regulatory components in cells expressing the RHO GTPase CDC42Hs.”
Esteve, et al.,Oncogene, 11:2657-2665, 1995, “Induction of apoptosis by rho in NIH 3T3 cells requires two complementary signals. Ceramides function as a progression factor for apoptosis.”
Gulbins, et al.,Journal of Biological Chemistry, 271(42):26389-26394, Oct. 18, 1996, “Fas-induced Apoptosis Is Mediated by Activation of a Ras and Rae Protein-regulated Signaling Pathway.”
Hirai, et al.,Journal of Biological Chemistry, 272(1):13-16, Jan. 3, 1997, “Geranylgeranylated Rho Small GTPases(s) Are Essential for the Degradation of p27Kip1and Facilitate the Progression from G1to S Phase in Growth-stimulated Rat FRTL-5 Cells.”
Hirata, et al.,Journal of Biological Chemistry, 267(13):8719-8722, May 5, 1992, “Involvement of rho p21 in the GTP-enhanced Calcium Ion Sensitivity of Smooth Muscle Contraction.”
Jimenez, et al.,Oncogene, 10:811-816, 1995, “Induction of apoptosis in NIH'3T3 cells after serum deprivation by overexpression of rho-p21, a GTPase protein of the ras superfamily.”
Katagiri, et al.,Journal of Cell Biology, 127(6) part 1:1755-1766, Dec. 1994, “Bone Morphogenetic Protein-2 Converts the Differentiation Pathway of C2C12 Myoblasts into the Osteoblast Lineage.”
Khosravi-Far, et al.,Molecular and Cellular Biology, 16(7):3923-3933, Jul. 1996, “Oncogenic Ras Activation of Raf/Mitogen-Activated Protein Kinase-Independent Pathways Is Sufficient To Cause Tumorigenic Transformation.”
Lamaze, et al.,Nature, 382:177-179, Jul. 11, 1996, “Regulation of receptor-mediated endocytosis by Rho and Rac.”
Lechner, et al.,Proc. Natl. Acad. Sci. USA, 93:4355-4359, Apr. 1996, “ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation.”
Minden, et al.,Cell, 81:1147-1157, 1995, “Selective Activation of the JNK Signaling Cascade and c-Jun Transcriptional Activity by the Small GTPases Rac and Cdc42Hs.”
Moorman, et al.,Journal of Immunology, 156:4146-4153, 1996, “Inactivation of the Small GTP Binding Protein Rho Induces Multinucleate Cell Formation and Apoptosis in Murine T Lymphoma EL41,2.”
Mourey, R. and J. Dixon,Current Opinion in Genetics and Development, 4:31-39, 1994, “Protein tyrosine phosphatases: characterization of extracellular and intracellular domains.”
Namiki, et al.,Journal of Biological Chemistry, 272(35):22046-22052, Aug. 29, 1997, “A Kinase Domain-truncated Type I Receptor Blocks Bone Morphogenetic Protein-2-induced Signal Transduction in C2C12 Myoblasts.”
Nobes, C. and A. Hall,Cell, 81:53-62, Apr. 7, 1995, “Rho, Rac, and Cdc42 GTPases Regulate the Assembly of Multimolecular Focal Complexes Associated with Actin Stress Fibers, Lamellipodia, and Filopodia.”
Olson, et al.,Science, 269:1270-1272, Sep. 1, 1995, “An Essential Role for Rho, Rac, and Cdc42 GTPases in Cell Cycle Progression Through G1.”
Qiu, et al.,Molecular and Cellular Biology, 17(6):3449-3458, Jun. 1997, “Cdc42 Regulates Anchorage-Independent Growth and Is Necessary for Ras Transformation.”
Roux, et al.,Current Biology, 7:629-637, 1997, “The Small GTPases Cdc42Hs, Rac1 and RhoG delineate Raf-independent pathways that cooperate to transform NIH3T3 cells.”
Seipl, et al.,Journal of Cell Science, 112:1825-1834, 1999, “Trio amino-terminal guanine nucleotide exchange factor domain expression promotes actin cytoskeleton reorganization, cell migration and anchorage-independent cell growth.”
Tapon, N. and A. Hall,Current Opinion in Cell Biology, 9:86-92, 1997, “Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton.”
Kong Haiyan
Stanton Lawrence
Zeng Wenlin
Knobbe Martens Olson & Bear LLP
Saidha Tekchand
Scios Inc.
Walicka Malgorzata A.
LandOfFree
Mediators of signal transduction does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mediators of signal transduction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mediators of signal transduction will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3519137